Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2022 Dec 8;19(24):16502.
doi: 10.3390/ijerph192416502.

Prevalence of Multimorbidity in the Middle East: A Systematic Review of Observational Studies

Kalpana Singh  1 , Albara Alomari  1 , Badriya Lenjawi  1
Affiliations
Meta-Analysis

Prevalence of Multimorbidity in the Middle East: A Systematic Review of Observational Studies

Kalpana Singh et al. Int J Environ Res Public Health. .

Abstract

Background: There has not been a review that evaluated the prevalence of multimorbidity in the Middle East. This review aims to measure the prevalence, demographic factors, and consequences of multimorbidity in the Middle East region.

Study design: A quantitative systematic review includes cross-sectional and longitudinal cohort studies.

Methods: The prevalence systematic review approach from the Joanna Briggs Institute was applied. We searched PsychINFO, MEDLINE, EMCARE, CINAHL, Scopus, Science Direct, and the Cochrane Central Register of Controlled Trials. Data were extracted methodically in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) standards. Studies written in English and released between 2012 and March 2022 were included. For the meta-analysis, a random-effects model was applied. PROSPERO registration number: CRD42022335534.

Results: The final sample consisted of eight cohort and observational studies. The number of participants varied from 354 to 796,427. Multimorbidity was present in all populations with a prevalence of 21.8% (95% confidence interval (CI): 21.7-21.8%).

Conclusion: Multimorbidity affects a significant section of the world's population. A uniform operationalization of multimorbidity is required in the Middle East in order to enable reliable estimates of illness burden, effective disease management, and resource distribution.

Keywords: Middle East; demographics association; multimorbidity; prevalence.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
PRISMA (Preferred Reporting Items for Systematic reviews and Meta-Analyses) flowchart of the literature search.
Figure 2
Figure 2
Multimorbidity prevalence in Middle East countries [22,23,24,25,26,27,28,29].
See this image and copyright information in PMC

References

    1. Ryan A., Wallace E., O’Hara P., Smith S.M. Multimorbidity and functional decline in community-dwelling adults: A systematic review. Health Qual. Life Outcomes. 2015;13:1–13. doi: 10.1186/s12955-015-0355-9. - DOI - PMC - PubMed
    1. Nunes B.P., Flores T.R., Mielke G.I., Thumé E., Facchini L.A. Multimorbidity and mortality in older adults: A systematic review and meta-analysis. Arch. Gerontol. Geriatr. 2016;67:130–138. doi: 10.1016/j.archger.2016.07.008. - DOI - PubMed
    1. Vetrano D.L., Palmer K., Marengoni A., Marzetti E., Lattanzio F., Roller-Wirnsberger R., Lopez Samaniego L., Rodríguez-Mañas L., Bernabei R., Onder G., et al. Frailty and multimorbidity: A systematic review and meta-analysis. J. Gerontol. A Biol. Sci. Med. Sci. 2019;74:659–666. doi: 10.1093/gerona/gly110. - DOI - PubMed
    1. The Academy of Medical Sciences . Multimorbidity a Priority for Global Health Research. Academy of Medical Sciences; London, UK: 2018.
    1. Salisbury C., Johnson L., Purdy S., Valderas J.M., Montgomery A.A. Epidemiology and impact of multimorbidity in primary care: A retrospective cohort study. Br. J. Gen. Pract. 2011;61:e12–e21. doi: 10.3399/bjgp11X548929. - DOI - PMC - PubMed

LinkOut - more resources